Mary A Markiewicz

8PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 08, 2025
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity.

Zoe K Bedrosian, Elizabeth M Ruark, Neekun Sharma

|May 07, 2021
Progesterone promotes immunomodulation and tumor development in the murine mammary gland.

Lauryn R Werner, Katelin A Gibson, Merit L Goodman

|Apr 03, 2019
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

Merit L Goodman, Gloria M Trinca, Katherine R Walter

|Sep 13, 2017
NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.

Neekun Sharma, Camille V Trinidad, Andrew P Trembath

Pageof 2